细菌素及其应用的研究进展

摘要/Abstract

摘要： 细菌素是细菌自身生产的一类杀菌物质,由基因编码、核糖体合成,是自然界中细菌用于调节自身菌群结构的一类重要活性物质。细菌素的来源广泛、结构多样,对各种动物致病菌都具有高效抑杀作用,这些特点为细菌素开发成为一种新型抗菌药物提供了可能。作者对近年来在细菌素生物学特征的发展、分类更新及其应用研究等进行了综述,希望能为中国新型细菌素类动物药物的开发提供参考。

关键词: 细菌素; 抗菌物质; 动物药物开发

Abstract: Bacteriocins, coded genetically and synthesized ribosomally, are a category of bactericidal peptides produced by bacteria. They play a key role in regulating environmental bacterial flora formation. With their wide resource, diverse structures and high potency in killing various pathogenic bacteria of animal diseases, bacteriocins are potentially developed into novel antimicrobials. This review focused on the research development of bacteriocin biological characteristics, the update of bacteriocin classification and the progress on application study of bacteriocins in last several years in order to throw some light on the development of novel bacteriocin veterinary drugs in China.

Key words: bacteriocin; antimicrobials; development of veterinary drugs

中图分类号:

刘宝生, 张锦华, 罗军荣. 细菌素及其应用的研究进展[J]. , 2013, (5): 123-128.

LIU Bao-sheng, ZHANG Jin-hua, LUO Jun-rong. Research Advance on Bacteriocin and its Application[J]. , 2013, (5): 123-128.

参考文献

1 刘宝生, 尚雅静, 张日俊. 细菌素在动物疾病防治中的作用和机理研究进展[J]. 中国兽医科学, 2010, 40(3): 321~326.
2 宋连花, 王彦文. 乳链菌肽(nisin)研究进展[J]. 食品研究与开发, 2004, 25(5): 18~21.
3 尚雅婧,张日俊. 细菌素应用的理论与实践[J]. 中国畜牧兽医, 2010, 37(5): 26~29.
4 Abriouel H, Franz C M, Omar N B, et al. Diversity and applications of Bacillus bacteriocins[J]. FEMS Microbiol Rev, 2011, 35(1): 201~232.
5 Borrero J, Brede D A, Skaugen M, et al. Characterization of garvicin ML, a novel circular bacteriocin produced by Lactococcus garvieae DCC43, isolated from mallard ducks (Anas platyrhynchos)[J]. Appl Environ Microbiol, 2011, 77(1): 369~373.
6 Chao L, Levin B R. Structured habitats and the evolution of anticompetitor toxins in bacteria[J]. Proc Natl Acad Sci USA, 1981, 78(10): 6324~6328.
7 Cotter P D, Hill C, Ross R P. Bacteriocins: Developing innate immunity for food[J]. Nat Rev Microbiol, 2005, 3(10): 777~788.
8 Daw M A, Falkiner F R. Bacteriocins: Nature, function and structure[J]. Micron, 1996, 27(6): 467~479.
9 Diaz M, Valdivia E, Martinez-Bueno M, et al. Characterization of a new operon, as-48EFGH, from the as-48 gene cluster involved in immunity to enterocin AS-48[J]. Appl Environ Microbiol, 2003, 69(2): 1229~1236.
10 Drider D, Fimland G, Hechard Y, et al. The continuing story of class Ⅱa bacteriocins[J]. Microbiol Mol Biol Rev, 2006, 70(2): 564~582.
11 Dubois J Y, Kouwen T R, Schurich A K, et al. Immunity to the bacteriocin sublancin 168 is determined by the suni (yolf) protein of Bacillus subtilis[J]. Antimicrob Agents Chemother, 2009, 53(2): 651~661.
12 Fontaine L, Boutry C, Guedon E, et al. Quorum-sensing regulation of the production of Blp bacteriocins in Streptococcus thermophilus[J]. J Bacteriol, 2007, 189(20): 7195~7205.
13 Frank S A. Spatial polymorphism of bacteriocins and other allelopathic traits[J]. Evolutionary Ecology, 1994, 8(4): 369~386.
14 Gillor O, Nigro L M, Riley M A. Genetically engineered bacteriocins and their potential as the next generation of antimicrobials[J]. Curr Pharm Des, 2005, 11(8): 1067~1075.
15 Gillor O, Ghazaryan L. Recent advances in bacteriocin application as antimicrobials[J]. Recent Pat Anti-infect Drug Discov, 2007, 2(2): 115~122.
16 Gillor O, Etzion A, Riley M. The dual role of bacteriocins as anti- and probiotics[J]. Appl Microbiol Biotechnol, 2008a, 81(4): 591~606.
17 Gillor O, Vriezen J A, Riley M A. The role of SOS boxes in enteric bacteriocin regulation[J]. Microbiology, 2008b, 154(Pt 6): 1783~1792.
18 Gillor O, Giladi I, Riley M A. Persistence of colicinogenic Escherichia coli in the mouse gastrointestinal tract[J]. BMC Microbiol, 2009, 9:165.
19 Guasch J F, Enfedaque J, Ferrer S, et al. Bacteriocin 28b, a chromosomally encoded bacteriocin produced by most Serratia marcescens biotypes.[J]. Res Microbiol, 1995, 146(6): 477~483.
20 Hale J D, Heng N C, Jack R W, et al. Identification of nlmTE, the locus encoding the ABC transport system required for export of nonlantibiotic mutacins in Streptococcus mutans [J]. J Bacteriol, 2005, 187(14): 5036~5039.
21 Hammami R, Zouhir A, Le L C, et al. BACTIBASE second release: A database and tool platform for bacteriocin characterization[J]. BMC Microbiol, 2010, 10:22.
22 Hauge H H, Nissen-Meyer J, Nes I F, et al. Amphiphilic alpha-helices are important structural motifs in the alpha and beta peptides that constitute the bacteriocin lactococcin G-enhancement of helix formation upon alpha-beta interaction[J]. Eur J Biochem, 1998, 251(3): 565~572.
23 Hechard Y, Sahl H G. Mode of action of modified and unmodified bacteriocins from gram-positive bacteria[J]. Biochimie, 2002, 84(5~6): 545~557.
24 Heng N C K, Wescombe P A, Burton J P, et al. The diversity of bacteriocins in gram-positive bacteria[M]. Bacteriocins: Ecology and Evolution, Riley M A, Chavan M A, Heidelberg, Germany:Springer, 2006.
25 Jack R W, Tagg J R, Ray B. Bacteriocins of gram-positive bacteria[J]. Microbiol Rev, 1995, 59(2): 171~200.
26 Kazazic M, Nissen-Meyer J, Fimland G. Mutational analysis of the role of charged residues in target-cell binding, potency and specificity of the pediocin-like bacteriocin sakacin P[J]. Microbiology, 2002, 148(Pt 7): 2019~2027.
27 Kirkup B C. Bacteriocins as oral and gastrointestinal antibiotics: Theoretical considerations, applied research, and practical applications[J]. Curr Med Chem, 2006, 13(27): 3335~3350.
28 Klaenhammer T R. Genetics of bacteriocins produced by lactic acid bacteria[J]. FEMS Microbiol Rev, 1993, 12(1~3): 39~85.
29 Kleerebezem M, Bongers R, Rutten G, et al. Autoregulation of subtilin biosynthesis in Bacillus subtilis: The role of the spa-box in subtilin-responsive promoters[J]. Peptides, 2004, 25(9): 1415~1424.
30 Klostermann K, Crispie F, Flynn J, et al. Efficacy of a teat dip containing the bacteriocin lacticin 3147 to eliminate gram-positive pathogens associated with bovine mastitis[J]. J Dairy Res, 2010, 77(2): 231~238.
31 Lagos R, Baeza M, Corsini G, et al. Structure, organization and characterization of the gene cluster involved in the production of microcin E492, a channel-forming bacteriocin[J]. Mol Microbiol, 2001, 42(1): 229~243.
32 Lagos R, Tello M, Mercado G, et al. Antibacterial and antitumorigenic properties of microcin E492, a pore-forming bacteriocin[J]. Curr Pharm Biotechnol, 2009, 10(1): 74~85.
33 Lancaster L E, Wintermeyer W, Rodnina M V. Colicins and their potential in cancer treatment[J]. Blood Cells Mol Dis, 2007, 38(1): 15~18.
34 Majeed H, Gillor O, Kerr B, et al. Competitive interactions in Escherichia coli populations: The role of bacteriocins[J]. International Society for Microbial Ecology, 2011, 5(1): 71~81.
35 Miller K W, Ray P, Steinmetz T, et al. Gene organization and sequences of pediocin Ach/PA-1 production operons in Pediococcus and Lactobacillus plasmids[J]. Lett Appl Microbiol, 2005, 40(1): 56~62.
36 Moll G N, Konings W N, Driessen A J M. Bacteriocins: Mechanism of membrane insertion and pore formation[J]. Antonie van Leeuwenhoek, 1999, 76:185~198.
37 Mota-Meira M, Morency H, Lavoie M C. In vivo activity of mutacin B-Ny266[J]. J Antimicrob Chemother, 2005, 56(5): 869~871.
38 Otto M, Peschel A, Göz F. Producer self-protection against the lantibiotic epidermin by the ABC transporter EpiFEG of Staphylococcus epidermidis Tü3298 [J]. FEMS Microbiol Lett, 1998, 166(2):203~211.
39 Piper C, Cotter P D, Ross R P, et al. Discovery of medically significant lantibiotics[J]. Curr Drug Discov Technol, 2009, 6(1): 1~18.
40 Podschun R, Ullmann U. Bacteriocin typing of Klebsiella spp. isolated from different sources[J]. Zentralbl Hyg Umweltmed, 1996, 198(3): 258~264.
41 Riley M A. Molecular mechanisms of bacteriocin evolution[J]. Annu Rev Genet, 1998, 32:255~278.
42 Riley M A, Chavan M A. Bacteriocins: Ecology and evolution[M]. Heidelberg, Germany:Springer,2006.
43 Riley M A. Bacteriocins, biology, ecology, and evolution[M]. Oxford:Elsevier, 2009.
44 Rojo-Bezares B, Saenz Y, Navarro L, et al. Coculture-inducible bacteriocin activity of Lactobacillus plantarum strain J23 isolated from grape must[J]. Food Microbiol, 2007, 24(5): 482~491.
45 Sanchez J, Borrero J, Gomez-Sala B, et al. Cloning and heterologous production of Hiracin jm79, a sec-dependent bacteriocin produced by Enterococcus hirae DCH5, in lactic acid bacteria and Pichia pastoris[J]. Appl Environ Microbiol, 2008, 74(8): 2471~2479.
46 Soliman W, Bhattacharjee S, Kaur K. Molecular dynamics simulation study of interaction between a class Ⅱa bacteriocin and its immunity protein.[J]. Biochim Biophys Acta, 2007, 1774(8): 1002~1013.
47 Sommer B, Friehs K, Flaschel E. Efficient production of extracellular proteins with Escherichia coli by means of optimized coexpression of bacteriocin release proteins[J]. J Biotechnol, 2010, 145(4): 350~358.
48 Stein T, Heinzmann S, Dusterhus S, et al. Expression and functional analysis of the subtilin immunity genes spaIFEG in the subtilin-sensitive host Bacillus subtilis MO1099 [J]. J Bacteriol, 2005, 187(3): 822~828.
49 Svetoch E A, Eruslanov B V, Perelygin V V, et al. Inducer bacteria, unique signal peptides, and low-nutrient media stimulate in vitro bacteriocin production by Lactobacillus spp. and Enterococcus spp. strains[J]. J Agric Food Chem, 2010, 58(10): 6033~6038.
50 Van B M, Derksen D J, Franz C M, et al. Structure function relationship of inducer peptide pheromones involved in Carnobacterium maltaromaticum and Enterococcus faecium [J]. Microbiology, 2007, 153(Pt 11): 3660~3666.
51 Zouhir A, Hammami R, Fliss I, et al. A new structure-based classification of gram-positive bacteriocins[J]. Protein J, 2010, 29(6): 432~439.

[1]	姜晶, 敖日格乐, 王纯洁, 张燕, 赵称赫, 吴宏军, 郝剑刚. 酸马奶提取植物乳杆菌DSM20174细菌素的理化特性研究[J]. , 2016, 43(2): 444-449.
[2]	卫旭彪, 武如娟, 郑召君, 马广, 廖秀冬, 张日俊. 喷雾干燥细菌素的生物学活性研究[J]. , 2015, 42(12): 3268-3273.
[3]	张建飞. 乳酸菌细菌素的纯化及应用的研究进展[J]. , 2012, 39(10): 225-228.
[4]	尚雅婧;张日俊. 细菌素应用的理论与实践[J]. , 2010, 37(5): 26-29.
[5]	余占桥;杨芳;张日俊. 细菌素异源表达的研究进展[J]. , 2010, 37(2): 51-54.
[6]	杨芳;余占桥;张日俊. 乳酸菌素基因PlnE和PlnF在大肠杆菌中的异源表达 [J]. , 2010, 37(12): 55-59.